Romer Orada, D.O., is a physical medicine and rehabilitation physician at Miami Cancer Institute. Dr. Orada specializes in cancer rehabilitation and treats patients who have impairments related to cancer or associated treatments. These include musculoskeletal disorders, neuropathy, weakness, gait difficulty, balance problems, spasticity, contracture, difficulty swallowing and lymphedema. He is fluent in English and Filipino/Tagalog. He works with a multidisciplinary team and uses treatments like non-opioid medications, targeted therapy/exercise prescriptions, therapeutic injections, bracing/orthotics, assistive devices and education to provide a comprehensive treatment plan for his patients with cancer-related impairments or disabilities. Dr. Orada joined Miami Cancer Institute from the University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, where he served as an assistant professor in the Department of Physical Medicine and Rehabilitation. During his cancer rehabilitation fellowship at Memorial Sloan Kettering Cancer Center in New York City, Dr. Orada served as a co-investigator for a case series of breast lymphedema. He is also a frequent speaker and lecturer on topics related to cancer rehabilitation. During his residency, Dr. Orada was named chief resident and resident of the year. He also served as the residency rotation director of the Cancer Rehabilitation PM&R rotation at the University of Pittsburgh Medical Center. Dr. Orada takes a holistic approach to caring for his patients. He considers their diagnosis and how the disease process affects a person’s overall well-being physically, emotionally, mentally, socially and spiritually. His goal is to optimize function, prevent further impairment and improve the quality of life for people undergoing cancer treatment, no matter where they are in the cancer journey. When he is not treating patients, Dr. Orada enjoys tennis, watching college basketball, trying new restaurants, anything outdoors, and traveling with his wife and family.